Geode Capital Management’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $123K | Buy |
|
|||||
|
2024
Q1 | $104K | Buy |
|
|||||
|
2023
Q4 | $84.1K | Hold |
|
|||||
|
2023
Q3 | $64.9K | Buy |
|
|||||
|
2023
Q2 | $67.5K | Sell |
|
|||||
|
2023
Q1 | $70.8K | Hold |
|
|||||
|
2022
Q4 | $64K | Sell |
|
|||||
|
2022
Q3 | $98K | Hold |
|
|||||
|
2022
Q2 | $117K | Sell |
|
|||||
|
2022
Q1 | $373K | Sell |
|
|||||
|
2021
Q4 | $1.13M | Sell |
|
|||||
|
2021
Q3 | $1.89M | Buy |
|
|||||
|
2021
Q2 | $2.85M | Buy |
|
|||||
|
2021
Q1 | $2.98M | Buy |
|